Resource

 

 

 

 

 

 

 

 

 

 

 

JV/Alliance/Licence

Slaughter and May advised Frieze - strategic partnership with WME | IMG

19 Apr 2016

Slaughter and May advised Frieze, a leading arts media and events company, on its strategic partnership with WME | IMG, a global leader in entertainment, sports and fashion.

Contacts

Corporate: Mark Zerdin (partner), Tom O’Neill (associate), Richard Batstone (associate); Employment: Jonathan Fenn (partner), Rosemary Nelson (associate); Tax: Gareth Miles (partner), Ed Moberly (associate); IP: Cathy Connolly (partner), Richard McDonnell (associate)

Slaughter and May advised Singbridge International Singapore Pte Ltd. - joint venture with China Merchants Land

19 Apr 2016

Slaughter and May advised Singbridge International Singapore Pte Ltd. (Singbridge), through its subsidiary Maxwell Investment and Development Pte Ltd. (Maxwell Investment), on its formation of a joint venture with Cosmos Harvest Development Limited (Cosmos Harvest), an indirectly wholly-owned subsidiary of China Merchants Land Limited.

Slaughter and May is advising Premier Foods - approach from McCormick and commercial collaboration with Nissin Foods

19 Apr 2016

Slaughter and May advised Premier Foods plc (Premier Foods) in relation to the takeover proposals received from McCormick & Company, Inc., regarding a possible all cash offer which valued Premier Foods at approximately £537 million. The latest proposal was rejected by Premier Foods’ board and McCormick has announced that it does not intend to make an offer for Premier Foods.

Austria: Schoenherr advises on joint venture for the construction and operation of the five-star Hotel Andaz am Belvedere

18 Apr 2016

Schoenherr advised Hyatt International, one of the biggest hotel investor and operator groups worldwide headquartered in Chicago, USA, on the establishment of a 50/50 joint venture structure for the construction and operation of a five-star hotel branded 'Andaz am Belvedere' together with the Austrian Signa Group.

Norton Rose Fulbright acts for Blue Sky Group in major student accommodation joint venture

15 Apr 2016

Norton Rose Fulbright has acted for Blue Sky Group in a student accommodation joint venture with Goldman Sachs.

Our Brisbane-based team negotiated and documented the joint venture arrangement for the acquisition and development of student accommodation sites throughout Australia and New Zealand. The 50/50 joint venture had an initial stage that required Goldman Sachs to contribute sufficient equity to buy a 50 per cent interest in three existing development sites owned by Blue Sky or funds that it managed.
 

Ashurst advises Westfield on joint venture with Commerz Real Investmentgesellschaft

13 Apr 2016

Ashurst advised Westfield on its 50/50 joint venture with Commerz Real Investmentgesellschaft (CRI), the German open-ended fund, in connection with the extension to the Westfield London shopping centre which, on completion, will be the largest mall in Europe.

The joint venture with CRI will extend the market leading retail scheme by over 500,000 square feet.

Hugh Lumby, global head of real estate, commented:

Herbert Smith Freehills advises Qatari Diar on £1.4 billion merger creating new force in London/UK residential market

13 Apr 2016

Herbert Smith Freehills has advised Qatari Diar Real Estate Investment Company, wholly owned by sovereign wealth fund Qatar Investment Authority, on the formation of a £1.4 billion residential property joint venture with Delancey’s flagship client fund DV4 and the Dutch pension fund asset manager APG, by means of the sale of interests in East Village (the former Olympic Village) and the acquisition of interests in the first phase of the Elephant & Castle Town Centre redevelopment.

Norton Rose Fulbright advises Pfizer on Parkinson’s disease research collaboration with IBM

12 Apr 2016

Norton Rose Fulbright New York and Washington, DC offices recently advised client Pfizer on a first-of-its-kind research collaboration with IBM to develop innovative remote monitoring solutions aimed at transforming how clinicians deliver care to patients suffering from Parkinson's disease.

Gowling WLG advises Heptares on $3.375 billion global R&D and commercialisation partnership to treat neurological disorders

12 Apr 2016

Gowling WLG's life sciences experts have advised long-standing client (Heptares Therapeutics (Heptares) on a definitive $3.375 billion agreement with Allergan Pharmaceuticals International Limited, a wholly-owned subsidiary of Allergan plc, a leading global pharmaceutical company.